Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Economic Policy Associates (CEPA) is an independent economics and finance advisory firm that provides strategic counsel to public and private sector clients globally. While not a drug developer, CEPA is highly relevant to the life sciences sector through its specialized Global Health practice, which focuses on health financing, market dynamics, and policy evaluation. The firm advises major international organizations, including Gavi, the Global Fund, and the Bill & Melinda Gates Foundation, on the procurement and distribution of vaccines and essential medicines. Their work often involves economic modeling to support regulatory decisions and the design of funding mechanisms for global health initiatives. CEPA's expertise helps bridge the gap between economic theory and practical health policy implementation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Economic Policy Associates.